HSBC TUR.WAR.OP.END. DYH/ DE000HS3CXS4 /
6/4/2024 9:36:45 PM | Chg.-0.0200 | Bid9:58:42 PM | Ask9:58:42 PM | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
0.3700EUR | -5.13% | 0.3600 Bid Size: 25,000 |
0.3700 Ask Size: 25,000 |
Target Corp | 111.9132 USD | 12/31/2078 | Call |
GlobeNewswire
10:15 PM
Royalty Pharma to Present at the Goldman Sachs 45th Annual Global Healthcare Conference
GlobeNewswire
10:15 PM
CEA Industries Inc. Announces Reverse Stock Split to be Effective June 7, 2024; Publicly Traded Warr...
GlobeNewswire
10:10 PM
ROSEN, A TOP RANKED LAW FIRM, Encourages Toyota Motor Corporation Investors to Inquire About Securit...
GlobeNewswire
10:10 PM
Abivax releases the results of its May 30, 2024 Ordinary and Extraordinary General Meeting
GlobeNewswire
10:06 PM
PennantPark Floating Rate Capital Ltd. Upsizes Credit Facility to $611 Million
GlobeNewswire
10:05 PM
Ocular Therapeutix® Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
10:05 PM
iRhythm Technologies to Present at the 2024 Truist Securities MedTech Conference
GlobeNewswire
10:05 PM
Consolidated Water Announces Settlement of Dispute with Mexico Regarding Playas de Rosarito, Baja Ca...
GlobeNewswire
10:05 PM
OrthoPediatrics Corp. to Participate in the Truist Securities MedTech Conference
GlobeNewswire
10:05 PM
HashiCorp and AWS sign strategic collaboration agreement to expand joint product and go-to-market in...
GlobeNewswire
10:05 PM
CARGO Therapeutics Adds Experienced Biopharma Executive to Board of Directors with the Appointment o...
GlobeNewswire
10:05 PM
Sportsman’s Warehouse Holdings, Inc. Announces First Quarter 2024 Financial Results
GlobeNewswire
10:01 PM
Ascendis Pharma to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference